NFATC1 and non-small cell lung carcinoma: Next, increased NFATc1 expression could also reverse the inhibitory effect of the miR‐338 overexpression on EMT markers of NSCLC cells (Figure 5d), decrease the expression of E‐cadherin enhanced by miR‐338 mimic, and increase the expressions of N‐cadherin and Vimentin reduced by miR‐338 mimic.